4//SEC Filing
GEORGIOU GEORGE 4
Accession 0001567619-18-001186
CIK 0001636282other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 4:40 PM ET
Size
11.1 KB
Accession
0001567619-18-001186
Insider Transaction Report
Form 4
GEORGIOU GEORGE
Director
Transactions
- Exercise/Conversion
Common Stock
2018-08-13$4.73/sh+20,000$94,600→ 175,861 total - Exercise/Conversion
Common Stock
2018-08-13$7.28/sh+17,333$126,184→ 155,861 total - Exercise/Conversion
Director Stock Option (right to buy)
2018-08-13−17,333→ 6,667 totalExercise: $7.28Exp: 2026-05-16→ Common Stock (17,333 underlying) - Exercise/Conversion
Director Stock Option (right to buy)
2018-08-13−20,000→ 10,000 totalExercise: $4.73Exp: 2027-11-30→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]The stock option vested and became exercisable, and shall continue to vest and become exercisable, in 36 equal monthly installments beginning on June 17, 2016, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.
- [F2]The stock option vested and became exercisable, and shall continue to vest and become exercisable, in 12 equal monthly installments beginning on January 1, 2018 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.
Documents
Issuer
Aeglea BioTherapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0000749811
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 4:40 PM ET
- Size
- 11.1 KB